Australian gov’t invests $360m in Medicare for women’s health

The package includes the first PBS listing of new oral contraceptive pills in over 30 years.

The Australian government has announced a $360m (A$573.3m) to improve women’s health as part of efforts to strengthen Medicare.

Key measures in the package include the first Pharmaceutical Benefits Scheme (PBS) listing of new oral contraceptive pills in over 30 years.

The package will also enhance access to long-term contraceptives by increasing Medicare payments and expanding bulk billing for intrauterine devices and birth control implants.

Support for women experiencing menopause will be expanded through a new Medicare rebate for menopause health assessments, funding for professional training, the introduction of the first-ever clinical guidelines, and a national awareness campaign.

In addition, the PBS will list new menopausal hormone therapies.

Some measures, including the PBS listings for the new contraceptive pills and menopausal hormone therapies, will take effect almost immediately.

A$1 = $0.63